Health-related quality of life in patients with common variable immunodeficiency switching from intravenous to subcutaneous immunoglobulin therapy
Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency disease (PID) among adults. CVID consists of two phenotypes - one in which infections are the characteristic and another in which impressive inflammatory and/or hematological complications also develop, i...
Saved in:
Main Authors: | Mona Al-Ahmad (Author), Ahmed Maher (Author), Jasmina Nurkic (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
by: M. Dolenc-Voljč, et al.
Published: (2013) -
Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
by: Suzanne Skoda-Smith, et al.
Published: (2009) -
Primary immunodeficiency: common variable immunodeficiency
by: Oksana Ussenova, et al.
Published: (2016) -
Does intravenous immunoglobulin therapy prolong immunodeficiency in transient hypogammaglobulinemia of infancy?
by: Lale Memmedova, et al.
Published: (2013) -
Predictors of shingles reports at diagnosis of common variable immunodeficiency and selective immunoglobulin G subclass deficiency in 212 Alabama adults
by: James C. Barton, et al.
Published: (2012)